Post from Truth Social

Dr. Jay Bhattacharya: "What President Trump has done is a historic measure that should have been done a long time ago. What we're going to do is make sure that those prices become much closer to equal like a competitive market you would expect."

Video transcript 1:36

So I teach economics at Stanford as well as health policy and one thing that's really really simple in economics Is that when you have a persistent price difference for the same product between two countries? There is something deeply wrong and what President Trump has done is a historic measure that should have been done a long time ago What we're going to do is is make sure that those prices Become much closer to equal like that like a competitive market you'd expect right now What's happening is the American people are subsidizing at in large large fraction Thought the research and development efforts for drug companies around the world by the higher prices that we pay with this new order Europe will share the burden of that and in fact if you may think of it as like it as somehow It's like it's it's going after drug companies Actually, it's helping drug companies because what we're also going to do with this order what President Trump has done with this order is He's said to European governments Look if you are taking advantage of the drug companies by forcing them to charge the very very low prices We're going to defend American drug companies in Europe at the same time We're standing up for the American consumer who's been paying far too high prices for far too long I can go back decades to point to Congressional report after a government report after government report of tremendously high drug prices Much higher than the rest of the world and nothing has been done about it until this moment And I'm really really proud President Trump so that you've done this I'm really proud to be included in this and looking forward to the work ahead

Transcribed automatically. Expect errors in names and numbers.

0:00 0:00
Visualize
2.5K 603 133

AI Analysis

Machine-generated analysis of the post above on 2026-03-22. Not written by the author of the post.

Danger Level
None
Narcissistic State
Grandiose
Authorship
Aide-Written
Intensity
20%
Authorship Analysis
Aide-Written
Indicators:
  • Clean quotation formatting
  • Proper attribution with title
  • Business hours posting (12:29 PM ET)
  • Attached video clip — comms team content
  • No editorial commentary or emotional markers
Psychological Profile
State
Grandiose State

Trigger: Supply Seeking (Drug pricing executive order)

Sentiment
+0.60
Clinical
Malignant Narcissism:
Narcissistic
50%
Antisocial
10%
Paranoid
0%
Sadism
0%
Defense Mechanisms:
idealization
Cognitive Complexity:
Complexity
30%
Parasocial Techniques:
authority endorsementsurrogate validation
Fact Checks (1)
"Drug prices to be cut by 59%"
Half True

Trump signed an executive order on most-favored-nation drug pricing in May 2025. The 59% figure likely refers to the gap between US and international prices, but actual implementation and realized savings were uncertain and subject to legal challenges and pharmaceutical industry pushback.

No contradictions with other posts detected yet.

Daily Digest Prescription Drug Executive Order Dominates a Carefully Orchestrated Policy Day, Bookended by Grievance

Trump's day was dominated by a coordinated rollout of an executive order on prescription drug pricing, which he promoted relentlessly across nearly half his posts. The morning opened with triumphant news about the release of American hostage Edan Alexander, followed by a midday policy blitz featurin...

Analyzed
20
Rage Level
12%
Max Danger
Elevated
View full day analysis →